Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 9,944,711

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,944,711
Title:Antibodies against human CD38
Abstract: Isolated monoclonal antibodies which bind to human CD38 and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies.
Inventor(s): De Weers; Michel (Houten, NL), Walseth; Tim (Roseville, MN), Van De Winkel; Jan (Zeist, NL), Vink; Tom (Alphen aan den Rijn, NL), Parren; Paul (Odijk, NL)
Assignee: GENMAB A/S (Copenhagen V, DK)
Application Number:14/990,869
Patent Claims:see list of patent claims

Details for Patent 9,944,711

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 1991-02-20 ⤷  Try it Free 2030-06-09
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 2000-06-28 ⤷  Try it Free 2030-06-09
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 1991-03-05 ⤷  Try it Free 2030-06-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.